Jayamas Medica Industri Stock Fundamentals
| OMED Stock | 184.00 1.00 0.54% |
Jayamas Medica Industri fundamentals help investors to digest information that contributes to Jayamas Medica's financial success or failures. It also enables traders to predict the movement of Jayamas Stock. The fundamental analysis module provides a way to measure Jayamas Medica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Jayamas Medica stock.
Jayamas |
Jayamas Medica Industri Company Return On Equity Analysis
Jayamas Medica's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Jayamas Medica Return On Equity | 0.52 |
Most of Jayamas Medica's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Jayamas Medica Industri is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Jayamas Medica Industri has a Return On Equity of 0.5195. This is 102.17% lower than that of the Healthcare sector and 108.69% lower than that of the Medical Instruments & Supplies industry. The return on equity for all Indonesia stocks is notably lower than that of the firm.
Jayamas Medica Industri Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Jayamas Medica's current stock value. Our valuation model uses many indicators to compare Jayamas Medica value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Jayamas Medica competition to find correlations between indicators driving Jayamas Medica's intrinsic value. More Info.Jayamas Medica Industri is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.56 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Jayamas Medica Industri is roughly 1.78 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Jayamas Medica's earnings, one of the primary drivers of an investment's value.Jayamas Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Jayamas Medica's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Jayamas Medica could also be used in its relative valuation, which is a method of valuing Jayamas Medica by comparing valuation metrics of similar companies.Jayamas Medica is rated below average in return on equity category among its peers.
Jayamas Fundamentals
| Return On Equity | 0.52 | |||
| Return On Asset | 0.29 | |||
| Profit Margin | 0.24 % | |||
| Operating Margin | 0.31 % | |||
| Current Valuation | 5.63 T | |||
| Shares Outstanding | 27.06 B | |||
| Shares Owned By Insiders | 8.00 % | |||
| Shares Owned By Institutions | 0.47 % | |||
| Price To Book | 5.55 X | |||
| Price To Sales | 2.76 X | |||
| Revenue | 2.19 T | |||
| Gross Profit | 904.29 B | |||
| EBITDA | 697.78 B | |||
| Net Income | 562.69 B | |||
| Book Value Per Share | 46.00 X | |||
| Cash Flow From Operations | 505.11 B | |||
| Earnings Per Share | 16.47 X | |||
| Number Of Employees | 1.03 K | |||
| Market Capitalization | 5.9 T | |||
| Last Dividend Paid | 10.87 |
About Jayamas Medica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Jayamas Medica Industri's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jayamas Medica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jayamas Medica Industri based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Jayamas Stock
Jayamas Medica financial ratios help investors to determine whether Jayamas Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jayamas with respect to the benefits of owning Jayamas Medica security.